Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles
Clinical trial NCT02820454 · COMPLETED
Trial details
- NCT number
- NCT02820454
- Sponsor
- University Hospital, Grenoble
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-02-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.